TY - JOUR
T1 - A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)
AU - Enciso-Mora, Victor
AU - Broderick, Peter
AU - Ma, Yussanne
AU - Jarrett, Ruth F.
AU - Hjalgrim, Henrik
AU - Hemminki, Kari
AU - van den Berg, Anke
AU - Olver, Bianca
AU - Lloyd, Amy
AU - Dobbins, Sara E.
AU - Lightfoot, Tracy
AU - van Leeuwen, Flora E.
AU - Foersti, Asta
AU - Diepstra, Arjan
AU - Broeks, Annegien
AU - Vijayakrishnan, Jayaram
AU - Shield, Lesley
AU - Lake, Annette
AU - Montgomery, Dorothy
AU - Roman, Eve
AU - Engert, Andreas
AU - von Strandmann, Elke Pogge
AU - Reiners, Katrin S.
AU - Nolte, Ilja M.
AU - Smedby, Karin E.
AU - Adami, Hans-Olov
AU - Russell, Nicola S.
AU - Glimelius, Bengt
AU - Hamilton-Dutoit, Stephen
AU - de Bruin, Marieke
AU - Ryder, Lars P.
AU - Molin, Daniel
AU - Sorensen, Karina Meden
AU - Chang, Ellen T.
AU - Taylor, Malcolm
AU - Cooke, Rosie
AU - Hofstra, Robert
AU - Westers, Helga
AU - van Wezel, Tom
AU - van Eijk, Ronald
AU - Ashworth, Alan
AU - Rostgaard, Klaus
AU - Melbye, Mads
AU - Swerdlow, Anthony J.
AU - Houlston, Richard S.
PY - 2010/12
Y1 - 2010/12
N2 - To identify susceptibility loci for classical Hodgkin's lymphoma (cHL), we conducted a genome-wide association study of 589 individuals with cHL (cases) and 5,199 controls with validation in four independent samples totaling 2,057 cases and 3,416 controls. We identified three new susceptibility loci at 2p16.1 (rs1432295, REL, odds ratio (OR) = 1.22, combined P = 1.91 x 10(-8)), 8q24.21 (rs2019960, PVT1, OR = 1.33, combined P = 1.26 x 10(-13)) and 10p14 (rs501764, GATA3, OR = 1.25, combined P = 7.05 x 10(-8)). Furthermore, we confirmed the role of the major histocompatibility complex in disease etiology by revealing a strong human leukocyte antigen (HLA) association (rs6903608, OR = 1.70, combined P = 2.84 x 10(-50)). These data provide new insight into the pathogenesis of cHL.
AB - To identify susceptibility loci for classical Hodgkin's lymphoma (cHL), we conducted a genome-wide association study of 589 individuals with cHL (cases) and 5,199 controls with validation in four independent samples totaling 2,057 cases and 3,416 controls. We identified three new susceptibility loci at 2p16.1 (rs1432295, REL, odds ratio (OR) = 1.22, combined P = 1.91 x 10(-8)), 8q24.21 (rs2019960, PVT1, OR = 1.33, combined P = 1.26 x 10(-13)) and 10p14 (rs501764, GATA3, OR = 1.25, combined P = 7.05 x 10(-8)). Furthermore, we confirmed the role of the major histocompatibility complex in disease etiology by revealing a strong human leukocyte antigen (HLA) association (rs6903608, OR = 1.70, combined P = 2.84 x 10(-50)). These data provide new insight into the pathogenesis of cHL.
KW - KAPPA-B-ALPHA
KW - REED-STERNBERG CELLS
KW - COLORECTAL-CANCER
KW - INFECTIOUS-MONONUCLEOSIS
KW - NEOPLASTIC-CELLS
KW - PROSTATE-CANCER
KW - INCREASED RISK
KW - C-MYC
KW - DISEASE
KW - GENE
U2 - 10.1038/ng.696
DO - 10.1038/ng.696
M3 - Article
SN - 1061-4036
VL - 42
SP - 1126-+
JO - Nature Genetics
JF - Nature Genetics
IS - 12
ER -